17 May 2023 ORYZON to present trial in progress Phase Ib FRIDA study at the upcoming 2023 ASCO annual meeting
5-8 June 2023 BIO International Conference 2023 Boston Convention & Exhibition Center in Boston MA United States
3 April 2023 ORYZON announces positive results from planned interim analysis of PORTICO, a Phase 2b adaptive trial in Borderline Personality Disorder